CNBC’s Angelica Peebles and Vertex JournavxPharmaceuticals CEO Reshma Kewalramani be a part of ‘Squawk on the Road’ to debate the FDA’s approval of the corporate’s non-opioid painkiller tablet Journavx, a brand new different for ache aid that comes with out the chance of dependancy, issues round drug effectiveness and prices, and extra.
Supply hyperlink
